Ainos, Inc. (NASDAQ:AIMD) Sees Significant Increase in Short Interest

Ainos, Inc. (NASDAQ:AIMD) saw a large growth in short interest in July. As of July 31st, there was short interest totaling 21,299 shares, a growth of 50.0% from the July 15th total of 14,197 shares. Based on an average trading volume of 36,032 shares, the short-interest ratio is currently 0.6 days. Approximately 0.3% of the company’s stock are sold short.

Insiders Place Their Bets

In other Ainos news, major shareholder Carbon Nano Technology Taiwan sold 41,000 shares of the stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $2.36, for a total value of $96,760.00. Following the sale, the insider directly owned 948,925 shares of the company’s stock, valued at approximately $2,239,463. This represents a 4.14% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Ting-Chuan Lee sold 109,988 shares of the firm’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $1.90, for a total transaction of $208,977.20. Following the completion of the sale, the director owned 807,417 shares in the company, valued at $1,534,092.30. The trade was a 11.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders bought 7,500 shares of company stock worth $15,435 and sold 179,788 shares worth $359,247. 9.79% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. DRW Securities LLC raised its stake in Ainos by 272.6% during the 4th quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock worth $109,000 after acquiring an additional 48,439 shares in the last quarter. Two Sigma Investments LP acquired a new position in Ainos in the third quarter valued at $80,000. Mariner LLC acquired a new position in Ainos in the fourth quarter valued at $37,000. Finally, Renaissance Technologies LLC grew its holdings in shares of Ainos by 13.1% during the fourth quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock worth $109,000 after purchasing an additional 7,700 shares during the last quarter.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, May 26th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

Ainos Price Performance

Shares of AIMD opened at $1.42 on Tuesday. The stock has a 50 day moving average price of $1.69 and a 200 day moving average price of $1.71. The company has a market capitalization of $10.49 million, a price-to-earnings ratio of -0.56 and a beta of 2.46. Ainos has a 52-week low of $1.26 and a 52-week high of $4.44.

Ainos (NASDAQ:AIMD) last released its quarterly earnings data on Monday, August 3rd. The company reported ($0.62) earnings per share for the quarter. The company had revenue of $0.15 million for the quarter. Ainos had a negative return on equity of 217.50% and a negative net margin of 11,912.10%.

Ainos Company Profile

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.